Venous thromboembolism is a blood clot in the skin veins that can occur in different parts of the body, usually in the leg. Venous thromboembolism, which is the most common disease after myocardial infarction and stroke among cardiovascular diseases, is a disease that occurs with the formation of blood clots in the deep veins of the lower extremities. If the blood clot is large, pulmonary embolism can turn into a fatal disease, as the blood flow can be blocked due to the blockage in the pulmonary artery. The rapid treatment of pulmonary embolism is of great importance in order to prevent life-threatening and prevent health problems that may occur.
MORE SUCCESSFUL RESULTS ARE OBTAINED BY STARTING TREATMENT EARLY
The clinical studies carried out prove that successful results can be obtained with the INVAMED Dovi Aspiration System, which is applied in the treatment of thrombosis, especially in the first 14-day period. Developed in the INVAMED Production Campus, the Dovi TromboJET Aspiration System provides high success in the patient group whose treatment is started in the early period and whose mortality is very high. The Dovi Suction Catheter, which gives effective results especially in the treatment of fresh and soft thrombi, offers a completely painless option for the patient with the perfect balance it provides between passage performance, bending resistance and thrombus-aspiration capacity.
HIGHER THAN BREAST CANCER AND AIDS DEATH TOTAL
In a statement on the subject, INVAMED President Raşit Dinç pointed out that early treatment in venous thromboembolism is life-saving and said, “Every 37 seconds in the world, a person dies as a result of venous thromboembolism, known as venous coagulation. This rate, which is more than the sum of deaths due to breast cancer and AIDS, once again reveals the severity of the disease. Dinç continued his statement as follows:
“The successful results obtained in this patient group, which is difficult to treat and poses a life risk, with the Dovi ThromboJET Aspiration System, which we developed as INVAMED in our Production Campus, show that venous thromboembolism is preventable as well as fatal.”